BIIB
Biogen Appoints Chuck Triano as Head of Investor Relations
Tuesday, March 14, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Biogen Appoints Chuck Triano as Head of Investor Relations
Price reaction · baseline $258.55 (2023-03-13 close) · hit after-hours · 1 other BIIB headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis
Full Press Release Details
Biogen Appoints Chuck Triano as Head of Investor Relations.